When is targeted radioisotope therapy recommended for prostate cancer?

The treatment uses a radioactive substance linked to a targeting molecule. The molecule seeks features on cancer cells, allowing radiation to be delivered near those cells. A specialist considers whether the cancer shows the target, whether it has spread or changed despite previous treatment, and whether your blood counts, kidney function and general health can support therapy. Imaging and laboratory tests help confirm these points.

Treatment may involve more than one visit, with monitoring between doses. Possible effects include tiredness, dry mouth, nausea, changes in blood counts and effects on nearby organs. Your team will explain precautions for contact with others and how treatment fits with other medicines.

Bring a list of medicines, supplements, allergies and earlier cancer treatments. Ask which scan or laboratory result establishes the treatment target, whether a biopsy or genetic test is needed, and what alternatives remain. Discuss kidney health, blood-count monitoring, fertility considerations and the practical radiation-safety instructions for home.

A referral to nuclear medicine and oncology specialists may be needed. Do not stop hormone treatment, pain medicines or other prescribed drugs unless your treating team gives you a plan.

Contact your oncology team promptly for fever, chills, unusual bleeding, repeated vomiting, worsening shortness of breath or confusion during treatment. Seek urgent care for severe breathing difficulty, fainting, heavy bleeding or sudden weakness. These symptoms need assessment regardless of whether radioisotope therapy has started.

Ask: Does my cancer carry the target this treatment requires? What tests will confirm that? What benefit are we aiming for, and how will we check it? Which side effects should be reported the same day? What other treatments could be used if this option is unsuitable?